Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,429 | 15,835 | 36,326 | 22,755 | 5,205 |
| Marketable Securities | 36,052 | 77,315 | 31,910 | 84,942 | N/A |
| TOTAL | $54,809 | $99,848 | $73,786 | $114,744 | $5,404 |
| Non-Current Assets | |||||
| PPE Net | N/A | 6,792 | 6,473 | 832 | 445 |
| Investments And Advances | 0 | 2,620 | 0 | 10,203 | 0 |
| Other Non-Current Assets | 130 | 572 | 774 | 497 | 532 |
| TOTAL | $130 | $9,984 | $7,247 | $11,532 | $977 |
| Total Assets | $54,939 | $109,832 | $81,033 | $126,276 | $6,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,080 | 1,990 | 1,979 | 141 |
| Accounts payable and accrued liabilities | 1,911 | 1,469 | 3,381 | 4,282 | 327 |
| Accrued Expenses | 6,066 | 5,943 | 2,675 | 1,710 | 1,497 |
| TOTAL | $8,115 | $8,492 | $8,046 | $7,971 | $1,965 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 1,042 | 2,951 | 4,824 |
| Other Non-Current Liabilities | 0 | 0 | 9 | 19 | 76 |
| TOTAL | $N/A | $N/A | $1,051 | $2,970 | $4,900 |
| Total Liabilities | $8,115 | $8,492 | $9,097 | $10,941 | $6,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,153 | 31,546 | 31,521 | 17,382 | N/A |
| Common Shares | 3 | 3 | 2 | 2 | 1 |
| Retained earnings | -211,791 | -141,736 | -90,564 | -43,001 | -14,826 |
| Other shareholders' equity | -30 | -42 | 29 | 17 | 11,648 |
| TOTAL | $46,824 | $101,340 | $71,936 | $115,335 | $-484 |
| Total Liabilities And Equity | $54,939 | $109,832 | $81,033 | $126,276 | $6,381 |